Allied Investment Advisors, LLC / ABT
Allied Investment Advisors, LLC’s Abbott Laboratories Position
Does Allied Investment Advisors, LLC own Abbott Laboratories (ABT)? Yes — 105.3K shares worth $11M (+1.55% of its 13F portfolio) as of Q1 2026, up from 98.0K shares the prior filed quarter.
Position Value
$11M
Q1 2026
Shares
105.3K
% of Portfolio
+1.55%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 105.3K | $11M | +1.55% |
| Q4 2025 | 98.0K | $12M | +1.90% |
| Q3 2025 | 94.6K | $13M | +2.02% |
| Q2 2025 | 89.6K | $12M | +2.13% |
| Q1 2025 | 90.1K | $12M | +2.27% |
| Q4 2024 | 86.6K | $10M | +1.97% |
| Q3 2024 | 84.7K | $10M | +1.91% |
| Q2 2024 | 82.5K | $9M | +2.01% |
| Q1 2024 | 79.6K | $9M | +2.18% |
| Q4 2023 | 75.7K | $8M | +2.27% |
| Q3 2023 | 74.3K | $7M | +2.15% |
| Q2 2023 | 71.1K | $8M | +2.24% |
| Q1 2023 | 69.7K | $7M | +2.19% |
| Q4 2022 | 67.7K | $7M | +2.33% |
| Q3 2022 | 66.0K | $6M | +2.38% |
| Q2 2022 | 63.7K | $7M | +2.48% |
| Q1 2022 | 61.9K | $7M | +2.39% |
| Q4 2021 | 59.0K | $8M | +2.84% |
| Q3 2021 | 58.3K | $7M | +2.60% |
| Q2 2021 | 58.5K | $7M | +2.55% |
| Q1 2021 | 56.9K | $7M | +2.92% |
| Q4 2020 | 55.8K | $6M | +2.93% |
| Q3 2020 | 56.4K | $6M | +3.30% |
| Q2 2020 | 58.0K | $5M | +3.05% |
| Q1 2020 | 61.3K | $5M | +3.49% |
| Q4 2019 | 61.6K | $5M | +3.16% |
| Q3 2019 | 61.0K | $5M | +3.29% |
| Q2 2019 | 61.2K | $5M | +3.45% |
| Q1 2019 | 62.0K | $5M | +3.44% |
| Q4 2018 | 64.3K | $5M | +3.84% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Allied Investment Advisors, LLC’s full portfolio or all institutional holders of ABT.